CME and CFTC Engage in Intense Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the U.S. Commodity Futures Trading Commission (CFTC) has escalated, with the CME suing the CFTC over its decision to allow blockchain-based perpetual future products. The CME argues that these products, known as perps, are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The dispute centers on the definition of a swap and whether perps should be classified as such, with the CME claiming that the CFTC is mislabeling the products and misapplying the law. The CFTC's decision to allow perps has been seen as a significant development in the rapidly growing arena of on-chain perpetual futures, with non-U.S. perps volume reportedly growing to $60 trillion in volume last year. The CME's lawsuit argues that the CFTC's approval of perps did not follow the proper protocol and that the regulator may not be prepared to enforce its emerging perps policy properly. The case is expected to have significant influence on how the U.S. approaches the growing arena of on-chain perpetual futures, with the CME and CFTC awaiting federal court action. The CFTC's decision to allow perps has been met with frustration and outrage from some, with Jake Chervinsky, CEO of the Hyperliquid Policy Center, stating that it is "unbelievably unusual" to see the largest exchange in America attacking its own regulator. The CME's attempt to fast-track 24/7 trading for crude oil futures was blocked by the CFTC, further escalating the dispute. The CFTC's Chairman, Mike Selig, has defended the regulator's decision, stating that the CME's decision to disregard the Commission's effort to undertake a reasoned analysis of the critical issues at stake is "wholly inappropriate." The CME's Chairman, Terry Duffy, has argued that the CFTC's approval of perps did not follow the proper protocol and that the regulator may not be prepared to enforce its emerging perps policy properly. The dispute has sparked a wider debate about the role of regulators in the growing arena of on-chain perpetual futures, with some arguing that the CFTC's decision to allow perps is a significant development in the evolution of the market. Others have raised concerns about the potential risks and challenges associated with perps, including the need for greater regulatory clarity and oversight. As the CME and CFTC await federal court action, the future of CFTC-driven perps remains uncertain, with the outcome of the case expected to have significant implications for the growing arena of on-chain perpetual futures.